Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Reducing Frailty for Older Cancer Survivors Using Supplements II [Phase 2]

View source ↗

Summary

This clinical trial update announces a Phase 2 study sponsored by the University of Rochester to evaluate whether dietary supplements can reduce frailty and inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Supplements

Snippet

Sponsor: University of Rochester | Conditions: Frailty, Inflammation | Phase 2 | Status: RECRUITING